130 related articles for article (PubMed ID: 11859853)
1. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
2. Relationship between serum angiotensin-converting enzyme activity and plasma plasminogen activator inhibitor activity in patients with recent myocardial infarction.
Moriyama Y; Ogawa H; Oshima S; Arai H; Takazoe K; Shimomura H; Hirai N; Suefuji H; Soejima H; Nishiyama K; Misumi K; Yasue H
Coron Artery Dis; 1998; 9(10):691-6. PubMed ID: 9894621
[TBL] [Abstract][Full Text] [Related]
3. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction.
Thögersen AM; Jansson JH; Wester PO
Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805
[TBL] [Abstract][Full Text] [Related]
4. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
Wiman B; Andersson T; Hallqvist J; Reuterwall C; Ahlbom A; deFaire U
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
[TBL] [Abstract][Full Text] [Related]
5. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
7. Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction.
Jansson JH; Boman K; Nilsson TK
Eur J Clin Pharmacol; 1993; 44(5):485-8. PubMed ID: 8359188
[TBL] [Abstract][Full Text] [Related]
8. Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.
Brännström M; Jansson JH; Boman K; Nilsson TK
Thromb Haemost; 1995 Aug; 74(2):612-5. PubMed ID: 8584993
[TBL] [Abstract][Full Text] [Related]
9. Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.
Mavrommatis AC; Theodoridis T; Economou M; Kotanidou A; El Ali M; Christopoulou-Kokkinou V; Zakynthinos SG
Intensive Care Med; 2001 Dec; 27(12):1853-9. PubMed ID: 11797019
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of the fibrinolytic system in myocardial infarction].
Moreno JA; Cornudella R; Gálvez M; Angós JA; Romero S; Gutiérrez M
Sangre (Barc); 1994 Feb; 39(1):23-7. PubMed ID: 8197514
[TBL] [Abstract][Full Text] [Related]
11. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning.
van Kesteren PJ; Kooistra T; Lansink M; van Kamp GJ; Asscheman H; Gooren LJ; Emeis JJ; Vischer UM; Stehouwer CD
Thromb Haemost; 1998 May; 79(5):1029-33. PubMed ID: 9609242
[TBL] [Abstract][Full Text] [Related]
12. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
[TBL] [Abstract][Full Text] [Related]
13. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction.
Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Nishiyama K
Clin Cardiol; 1997 May; 20(5):441-5. PubMed ID: 9134274
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of fibrinolytic factors in coronary heart disease.
Wiman B
Scand J Clin Lab Invest Suppl; 1999; 230():23-31. PubMed ID: 10389198
[TBL] [Abstract][Full Text] [Related]
15. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
16. Effects of octreotide on epidermal growth factor receptor, tissue plasminogen activator, and plasminogen activator inhibitor during intraperitoneal adhesion formation.
Lai HS; Chen Y; Chang KJ; Chen WJ
J Gastroenterol; 2003; 38(6):555-60. PubMed ID: 12825131
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
[TBL] [Abstract][Full Text] [Related]
18. Comparison of three doses of enalapril in preventing left ventricular remodeling after acute myocardial infarction in the rat.
Yang Y; Zhang P; Song L; Ruan Y; Xu X; Li Y; Zhou Y; Tian Y; Xu Y; Chen Z
Chin Med J (Engl); 2002 Mar; 115(3):347-51. PubMed ID: 11940361
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension.
Sakata K; Shirotani M; Yoshida H; Urano T; Takada Y; Takada A
Am Heart J; 1999 Jun; 137(6):1094-9. PubMed ID: 10347337
[TBL] [Abstract][Full Text] [Related]
20. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators.
Vaughan DE; Rouleau JL; Ridker PM; Arnold JM; Menapace FJ; Pfeffer MA
Circulation; 1997 Jul; 96(2):442-7. PubMed ID: 9244210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
